The Use of Real-World Evidence to Support Regulatory and Reimbursement Decisions [ 1/1/2021 - 12/31/2023 ]

Research Grant

Brief description Traditionally, medicines are studied extensively in clinical trials before they are widely available. More recently, some medicines have been allowed to enter the market without complete data on their benefits and risks. This means that these issues can only be studied once a medicine is on the market and used in routine clinical practice; this is referred to as real-world evidence. This research evaluates if this evidence is sufficient to prove that a medicine is safe and that it works

Funding Amount $91,538

Funding Scheme Postgraduate Scholarships

Chief Investigator Ms Dominique Favell

Notes Public Health and Health Services Research Scholarship